FDA Approved: PROCRIT — Supplemental Application (Janssen Products, LP)

View source ↗

Summary

FDA approved Janssen Products, LP's supplemental application for PROCRIT (erythropoietin), updating the product labeling under BLA103234.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia Due to Chronic Kidney Disease
• Chemotherapy-induced Anemia
• HIV Infection-related Anemia

Drugs mentioned

• PROCRIT (ERYTHROPOIETIN)

Snippet

SUPPL AP for PROCRIT (ERYTHROPOIETIN)